In other words, loss of p53, one of the most common molecular abnormalities in cancer, contributes to the glycolytic environment in cancer promoting glycolysis and inhibiting mitochondrial GO and function (Burns and Richter, 2008; Vousden and Ryan, 2009). This evidence concerns the gene TP53 and cancer.